DK0524517T3 - Substituerede 3,4-dihydronaphtalener, lægemidler indeholdende disse forbindelser og fremgangsmåder til fremstilling af forbindelserne - Google Patents
Substituerede 3,4-dihydronaphtalener, lægemidler indeholdende disse forbindelser og fremgangsmåder til fremstilling af forbindelserneInfo
- Publication number
- DK0524517T3 DK0524517T3 DK92111875.8T DK92111875T DK0524517T3 DK 0524517 T3 DK0524517 T3 DK 0524517T3 DK 92111875 T DK92111875 T DK 92111875T DK 0524517 T3 DK0524517 T3 DK 0524517T3
- Authority
- DK
- Denmark
- Prior art keywords
- compounds
- radical
- denotes
- image
- dihydronaphthalenes
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C275/00—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
- C07C275/64—Derivatives of urea, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups having nitrogen atoms of urea groups singly-bound to oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C259/00—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups
- C07C259/04—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids
- C07C259/06—Compounds containing carboxyl groups, an oxygen atom of a carboxyl group being replaced by a nitrogen atom, this nitrogen atom being further bound to an oxygen atom and not being part of nitro or nitroso groups without replacement of the other oxygen atom of the carboxyl group, e.g. hydroxamic acids having carbon atoms of hydroxamic groups bound to hydrogen atoms or to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/14—All rings being cycloaliphatic
- C07C2602/26—All rings being cycloaliphatic the ring system containing ten carbon atoms
- C07C2602/28—Hydrogenated naphthalenes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Immunology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE4124345A DE4124345A1 (de) | 1991-07-23 | 1991-07-23 | Substituierte 3,4-dihydronaphthaline, diese verbindungen enthaltende arzneimittel und verfahren zur herstellung dieser verbindungen und arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
DK0524517T3 true DK0524517T3 (da) | 1995-11-06 |
Family
ID=6436795
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK92111875.8T DK0524517T3 (da) | 1991-07-23 | 1992-07-13 | Substituerede 3,4-dihydronaphtalener, lægemidler indeholdende disse forbindelser og fremgangsmåder til fremstilling af forbindelserne |
Country Status (10)
Country | Link |
---|---|
US (1) | US5254731A (da) |
EP (1) | EP0524517B1 (da) |
JP (1) | JP3163173B2 (da) |
AT (1) | ATE124035T1 (da) |
AU (1) | AU650154B2 (da) |
CA (1) | CA2070495A1 (da) |
DE (2) | DE4124345A1 (da) |
DK (1) | DK0524517T3 (da) |
ES (1) | ES2076623T3 (da) |
HK (1) | HK1005179A1 (da) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP3007138B2 (ja) * | 1990-11-27 | 2000-02-07 | ファイザー製薬株式会社 | 新規なヒドロキサム酸とn―ヒドロキシ尿素誘導体およびそれらの組成物 |
WO1995002575A1 (en) * | 1993-07-14 | 1995-01-26 | Smithkline Beecham Corporation | 5-lipoxygenase inhibitors |
DE602004021573D1 (de) | 2003-04-07 | 2009-07-30 | Pharmacyclics Inc | Hydroxamate als therapeutische mittel |
PT2099442E (pt) * | 2006-12-26 | 2015-02-10 | Pharmacyclics Inc | Métodos de utilização de inibidores de histona desacetilase e monitorização de biomarcadores em terapia de combinação |
EP2993473A1 (en) * | 2007-01-30 | 2016-03-09 | Pharmacyclics, Inc. | Methods for determining cancer resistance to histone deacetylase inhibitors |
US8603521B2 (en) | 2009-04-17 | 2013-12-10 | Pharmacyclics, Inc. | Formulations of histone deacetylase inhibitor and uses thereof |
BRPI1014405A2 (pt) | 2009-04-29 | 2016-04-05 | Amarin Corp Plc | composições farmacêuticas compreendendo epa e um agente cardiovascular e métodos de seu uso |
EP2755648B1 (en) | 2011-09-13 | 2017-03-08 | Pharmacyclics LLC | Formulations of histone deacetylase inhibitor in combination with bendamustine and uses thereof |
EP3027192A4 (en) | 2013-08-02 | 2017-03-22 | Pharmacyclics, LLC | Methods for the treatment of solid tumors |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0279263B1 (en) * | 1987-02-10 | 1993-08-04 | Abbott Laboratories | Indole, benzofuran, benzothiophene containing lipoxygenase inhibiting compounds |
DE3888574T2 (de) * | 1987-04-24 | 1994-06-30 | Abbott Lab | Harnstoff-Derivate mit lipoxygenasehemmender Wirkung. |
JPH027494A (ja) * | 1988-06-24 | 1990-01-11 | Fujitsu Ltd | プリント基板のメッキ装置 |
AU4717889A (en) * | 1988-12-29 | 1990-07-05 | Ciba-Geigy Ag | Amino-substituted hydroxamic acids |
GB8830427D0 (en) * | 1988-12-30 | 1989-03-01 | Fujisawa Pharmaceutical Co | New hydroxylamine derivatives,a process for the preparation thereof and pharmaceutical composition comprising the same |
JPH04504261A (ja) * | 1989-03-30 | 1992-07-30 | アボツト・ラボラトリーズ | 尿素系リポキシゲナーゼ阻害化合物 |
JP3065636B2 (ja) * | 1989-06-29 | 2000-07-17 | 塩野義製薬株式会社 | [ジ―tert―ブチル(ヒドロキシ)フェニルチオ]置換ヒドロキサム酸誘導体 |
WO1991005757A1 (en) * | 1989-10-19 | 1991-05-02 | Schering Corporation | Lipoxygenase inhibitors |
US5220059A (en) * | 1990-04-19 | 1993-06-15 | Abbott Laboratories | Lipoxygenase-inhibiting compounds derived from non-steroidal antiinflammatory carboxylic acids |
-
1991
- 1991-07-23 DE DE4124345A patent/DE4124345A1/de not_active Withdrawn
-
1992
- 1992-06-04 CA CA002070495A patent/CA2070495A1/en not_active Abandoned
- 1992-07-10 US US07/911,625 patent/US5254731A/en not_active Expired - Lifetime
- 1992-07-13 DK DK92111875.8T patent/DK0524517T3/da active
- 1992-07-13 AT AT92111875T patent/ATE124035T1/de not_active IP Right Cessation
- 1992-07-13 DE DE59202599T patent/DE59202599D1/de not_active Expired - Lifetime
- 1992-07-13 EP EP92111875A patent/EP0524517B1/de not_active Expired - Lifetime
- 1992-07-13 ES ES92111875T patent/ES2076623T3/es not_active Expired - Lifetime
- 1992-07-15 AU AU20310/92A patent/AU650154B2/en not_active Ceased
- 1992-07-22 JP JP19568092A patent/JP3163173B2/ja not_active Expired - Fee Related
-
1998
- 1998-05-19 HK HK98104296A patent/HK1005179A1/xx not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
CA2070495A1 (en) | 1993-01-24 |
JPH05194350A (ja) | 1993-08-03 |
ES2076623T3 (es) | 1995-11-01 |
HK1005179A1 (en) | 1998-12-24 |
EP0524517A1 (de) | 1993-01-27 |
ATE124035T1 (de) | 1995-07-15 |
JP3163173B2 (ja) | 2001-05-08 |
AU2031092A (en) | 1993-01-28 |
DE59202599D1 (de) | 1995-07-27 |
DE4124345A1 (de) | 1993-01-28 |
AU650154B2 (en) | 1994-06-09 |
US5254731A (en) | 1993-10-19 |
EP0524517B1 (de) | 1995-06-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK116480A (da) | Fremgangsmaade til fremstilling af substituerede chromoner | |
DE3062609D1 (en) | Muramyldipeptide derivatives, process for preparing said compounds and pharmaceutical compositions containing said compounds | |
US4476308B1 (da) | ||
AU6954887A (en) | Oligopeptidyl nitrile derivatives, agents containing them, a process for their preparation, and their use | |
DK0524517T3 (da) | Substituerede 3,4-dihydronaphtalener, lægemidler indeholdende disse forbindelser og fremgangsmåder til fremstilling af forbindelserne | |
ES8505518A1 (es) | Procedimiento para preparar derivados de aminoacidos | |
DK288686A (da) | Farmaceutiske praeparater | |
GB1550496A (en) | 1,2,3,3a4,5-hexahydro-canthine derivatives a process for their preparation and their therapeutic applications | |
DK0468281T3 (da) | Substituerede phenylacetylener, lægemidler indeholdende disse og fremgangsmåder til fremstilling af disse forbindelser og lægemidler | |
DK165247C (da) | 2,3,4,5-substituerede 1,6-naphthyridinderivater, deres fremstilling samt anvendelse af disse til fremstilling af laegemidler til bekaempelse af cardiale, cerebrale og perifere karlidelser, myocardial iskaemi, cerebral infarkt, lungethrombose, stenoser, arterioscleroser og hjerte-kredsloebslidelser og laegemiddel indeholdende disse derivater | |
DK439082A (da) | 4-acylamino-1-aza-adamantan-forbindelser samt fremgangsmaade til fremstilling deraf | |
GB2017087A (en) | Process for the preparation of xanthone derivatives | |
SE8303719D0 (sv) | Novel eburnane oxime derivatives and process for preparing same | |
AU8896182A (en) | Imidazolylcarboxylic acids and derivative | |
GB1545077A (en) | Process for purifying water using bis-isothiouronium salts | |
JPS5210218A (en) | Preparation of beta-sulfenylacrylamides | |
DE3660546D1 (en) | Phosphoroimidates | |
ES465568A1 (es) | Procedimiento para la preparacion de acidos 2-amino-ciclo- pent-1-en-1-carboxilicos en n | |
JPS5287139A (en) | Cyanoaniline derivative |